[28P2-am2] Clinical Pharmacy 5/Social pharmacy 2

[28P2-am2-164] Cost-Utility Analysis of Companion Diagnostics in Olaparib Therapy for Advanced Recurrent Ovarian Cancer

○Toshihiro Shida¹, Tadao Inoue², Ichiro Arakawa³, Jiro Ogura¹, Manabu Seino⁴, Tsuyoshi Ohta⁴, Satoru Nagase⁴, Hiroaki Yamaguchi¹ (1. Dept. Pharm., Yamagata Univ. Hosp., 2. Sch. Pharm. Sci., Ohu Univ., 3. Grad. Med., Fac. Med., Tokyo Univ., 4. Dept. Obstet. Gynecol., Yamagata Univ. Fac. Med.)